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abstract
 
Measurements of membrane capacitance were applied to dissect the cellular mechanisms underlying
PKA-dependent and -independent stimulation of insulin secretion by cyclic AMP. Whereas the PKA-independent
(Rp-cAMPS–insensitive) component correlated with a rapid increase in membrane capacitance of 
 
 
 
80 fF that pla-
teaued within 
 
 
 
200 ms, the PKA-dependent component became prominent during depolarizations 
 
 
 
450 ms. The
PKA-dependent and -independent components of cAMP-stimulated exocytosis differed with regard to cAMP con-
 
centration dependence; the 
 
K
 
d
 
 values were 6 and 29 
 
 
 
M for the PKA-dependent and -independent mechanisms,
respectively. The ability of cAMP to elicit exocytosis independently of PKA activation was mimicked by the selective
cAMP-GEFII agonist 8CPT-2Me-cAMP. Moreover, treatment of B-cells with antisense oligodeoxynucleotides
against cAMP-GEFII resulted in partial (50%) suppression of PKA-independent exocytosis. Surprisingly, B-cells in
islets isolated from SUR1-deﬁcient mice (SUR1
 
 
 
/
 
 
 
 mice) lacked the PKA-independent component of exocytosis.
Measurements of insulin release in response to GLP-1 stimulation in isolated islets from SUR1
 
 
 
/
 
 
 
 mice conﬁrmed
the complete loss of the PKA-independent component. This was not attributable to a reduced capacity of GLP-1 to
elevate intracellular cAMP but instead associated with the inability of cAMP to stimulate inﬂux of Cl
 
 
 
 into the
granules, a step important for granule priming. We conclude that the role of SUR1 in the B cell extends beyond
being a subunit of the plasma membrane K
 
ATP
 
-channel and that it also plays an unexpected but important role in
the cAMP-dependent regulation of Ca
 
2
 
 
 
-induced exocytosis.
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INTRODUCTION
 
Insulin secretion from the pancreatic B-cells is controlled
by metabolic fuels, neurotransmitters released from in-
traislet nerve endings, paracrine mechanisms, and circu-
lating hormones (Ashcroft and Rorsman, 1989; Satin and
Kinard, 1998). Several modulators of insulin secretion act
by activation of protein kinases and phosphatases (Nesher
et al., 2002). For example, the capacity of glucagon, GLP-1,
and GIP to enhance insulin secretion involves stimula-
tion of adenylate cyclase with resultant increase in the in-
tracellular cAMP concentration (Gromada et al., 1998).
Cyclic AMP initiates several processes that culminate in
enhancement of insulin secretion. These include stimula-
 
tion of electrical activity by a reduction of K
 
ATP
 
-channel ac-
 
tivity (Holz et al., 1993), increase of the L-type Ca
 
2
 
 
 
-cur-
rent (Ämmälä et al., 1993; Kanno et al., 1998), activation
of depolarizing cation-permeable ion channels (Leech
and Habener, 1997), mobilization of Ca
 
2
 
 
 
 from intracellu-
lar stores (Gromada et al., 1995; Kang et al., 2001), and an
effect on the release process itself (Jones et al., 1988).
Many of these effects are likely to be mediated by activa-
tion of PKA. However, there is increasing evidence that
PKA-independent mechanisms are also signiﬁcant. For
example, the ability of cAMP to mobilize Ca
 
2
 
 
 
 from intra-
cellular stores is mediated by the cAMP receptor protein
cAMP-GEFII (Kang et al., 2001) and we and others have
demonstrated previously that the effects of cAMP on se-
cretion involves both PKA-dependent and -independent
mechanisms (Renström et al., 1997; Ozaki et al., 2000).
The latter pathway appears to be mediated by cAMP-
GEFII and this protein has been suggested to play a prom-
inent role in incretin-induced insulin secretion (Nakazaki
et al., 2002). Exactly how cAMP, via binding to cAMP-
GEFII, promotes exocytosis remains unestablished but
the effect may involve Rim2 (Ozaki et al., 2000). RIM pro-
teins have recently been shown to promote priming of
granules for release in neurons (Wang et al., 1997; Schoch
et al., 2002) and it is tempting to speculate that they fulﬁl
a similar function in the B cell.
Here we have studied the PKA-dependent and -inde-
pendent effects of cAMP on insulin secretion in B-cells
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taken from wild-type and SUR1 knockout mice. We
demonstrate that the PKA-independent pathway of
cAMP accounts for a rapid component of release that
appears particularly signiﬁcant for incretin-stimulated
insulin secretion. We ﬁnally propose a working model
for the regulation of exocytosis in the B cell that incor-
porates Rim2, cAMP-GEFII, and SUR1 in granule prim-
ing and release.
 
MATERIALS AND METHODS
 
Animals, Isolation of Islets, and Preparation
and Culture of B-cells
 
Most experiments were performed on B-cells isolated from
NMRI-mice (Bomholtgaard). The mice lacking the SUR1 recep-
tor (SUR1
 
 
 
/
 
 
 
 mice; 6–12 mo of age) used in this study were ob-
tained from Dr. M. Magnuson (Shiota et al., 2002) and bred at
the Karolinska Institute in Stockholm. The mice were killed by
cervical dislocation, the pancreas was quickly removed, and islets
were isolated by collagenase digestion. The procedures for sacri-
ﬁcing the animals were approved by the ethical committee at
Lund University and by local authorities in Hamburg.
For electrophysiology, the islets were dissociated into single
cells using a Ca
 
2
 
 
 
-free solution. The resulting cell suspension was
plated on Corning petri dishes or glass coverslips (for confocal
microscopy) and maintained in tissue culture for 6–30 h in RPMI
1640 medium containing 10% (vol/vol) fetal calf serum, 100 
 
 
 
g/
ml streptomycin, and 100 i.u./ml penicillin.
The inﬂuence of the cAMP-binding protein cAMP-GEFII,
which mediates cAMP-dependent but PKA-independent exocyto-
sis (Ozaki et al., 2000), was tested by culturing intact islets from
NMRI-mice in the presence of 4 
 
 
 
M of antisense phosphorothio-
ate–substituted oligodeoxynucleotides (ODNs)* against mouse
cAMP-GEFII (5
 
 
 
-CAACGGCCTTTTATCC-3
 
 
 
) or control ODNs
(5
 
 
 
-ACCTACGTGACTACGT-3
 
 
 
) (provided by S. Seino, Chiba
University, Japan) for 96 h. The control ODNs were made such
that chemical properties were similar to that of antisense ODN
(Ozaki et al., 2000). These islets were then dissociated into single
cells and cultured as described above. Most cells prepared from
islets cultured for 4 d had small exocytotic responses. The analy-
sis of the effects of treatment with antisense cAMP-GEFII or the
control ODN was therefore conﬁned to the ﬁve cells in each
group displaying the largest capacitance increases (the total
number of cells analyzed was 114). Because of the difﬁculty
maintaining secretion in primary B-cells, some experiments (Fig.
4, C–E) were instead performed using mouse insulinoma MIN6
cells (Miyazaki et al., 1990). These were either treated with the
control and antisense ODNs speciﬁed above for 96 h or were sub-
jected to transient transfection using mutant cAMP-GEF-II ex-
pression vector pSR
 
 
 
-cAMP-GEFII (G114E/G422D; provided by
S. Seino) reconstituted in effectene transfection reagent (QIA-
GEN). The cells were cotransfected with eGFP (CLONTECH
Laboratories, Inc.) To facilitate the identiﬁcation of the trans-
fected cells. Electrophysiological experiments were performed
 
 
 
36 h after transfection.
 
Solutions
 
The extracellular solution consisted of (in mM) 118 NaCl, 20 tet-
raethylammonium-chloride (TEA-Cl), 5.6 KCl, 1.2 MgCl
 
2
 
, 2.6
 
CaCl
 
2
 
, 5 D-glucose, and 5 HEPES (pH 7.4 with NaOH). In the
perforated patch experiments, forskolin (2–10 
 
 
 
M; from Sigma-
Aldrich) or GLP-1 (10 nM; Peninsula Laboratories) was added to
increase intracellular cAMP levels and enhance exocytosis (Äm-
mälä et al., 1993). PKA was inhibited by treating the cells with the
membrane-permeant cAMP antagonists Rp-cAMPS or Rp-8-Br-
cAMPS (Biologic) for 
 
 
 
5 min. The pipette solution used for the
perforated patch measurements contained (in mM) 76 Cs
 
2
 
SO
 
4
 
,
10 NaCl, 10 KCl, 1 MgCl
 
2
 
, and 5 HEPES (pH 7.35 with CsOH).
The pipette solution in the standard whole-cell measurements in
which the cells were stimulated with voltage-clamp depolariza-
tions consisted of (in mM) 125 Cs-glutamate, 10 CsCl, 10 NaCl, 1
MgCl
 
2
 
, 0.05 EGTA, 3 Mg-ATP, 5 HEPES (pH 7.1 using CsOH; in-
tracellular solution I). Cyclic AMP or the selective cAMP-GEFII-
agonist 8-(4-chloro-phenylthio)-2
 
 
 
-O-methyladenosine-3
 
 
 
,5
 
 
 
-cyclic
monophosphate (8CPT-2Me-cAMP; Enserink et al., 2002) was
added to the latter solution at the indicated concentrations. To
block PKA, Rp-cAMPS was included at a concentration of 0.5
mM. When exocytosis was stimulated by infusion of a buffer with
elevated [Ca
 
2
 
 
 
]
 
i
 
 (Figs. 4, C–E, 9, and 10), the pipette solution
contained (in mM) 125 K-glutamate, 10 KCl, 10 NaCl, 1 MgCl
 
2
 
,
3 Mg-ATP, 5 HEPES (pH 7.15 with KOH), 5 or 9 CaCl
 
2
 
, and 10
EGTA (intracellular solution II). The free Ca
 
2
 
 
 
 concentrations
were estimated to be 0.17 and 1.5 
 
 
 
M using the binding con-
stants of Martell and Smith (1974).
 
Electrophysiology
 
Patch electrodes were made from borosilicate glass capillaries
coated with Sylgard close to the tips and ﬁre-polished. The pi-
pette resistance ranged between 2 and 4 M
 
 
 
 when the pipettes
were ﬁlled with the intracellular solutions speciﬁed above. The
zero-current potential of the pipette was adjusted in the bath be-
fore giga-seal formation. Either the perforated patch whole-cell
technique (Figs. 1 and 4, A and B), in which the cells remain
metabolically intact, or the standard whole-cell conﬁguration
(Figs. 2, 3, 4, C–E, 5, 7, 9, and 10), which allows intracellular ap-
plication of reagents simply by including them in the pipette so-
lution, was used. All measurements were conducted using EPC7
or EPC9 patch-clamp ampliﬁers and the Pulse software (version
8.30 or later; Heka Elektronik).
Exocytosis was detected as changes in cell capacitance, which
was estimated by the Lindau-Neher technique (Gillis, 1995), im-
plementing the “Sine 
 
 
 
 DC”-feature of the lock-in module (40
mV peak-to-peak and a frequency of 500–1,000 Hz). Secretion
was elicited by single voltage-clamp depolarizations from 
 
 
 
70 to
0 mV of variable duration or trains of 10 500-ms depolarizations
(1-Hz stimulation frequency) to 0 mV. During the experiments,
the cells were continuously superfused with the extracellular me-
dium at a rate of 
 
 
 
2 ml/min and the volume of the chamber re-
duced to 0.5 ml by a plastic insert. All electrophysiological mea-
surements were performed at 
 
 
 
33
 
 
 
C.
 
Immunocytochemistry
 
Primary B-cells and MIN-6 cells were ﬁxed in 3% paraformalde-
hyde in K-PIPES (Sigma-Aldrich) and permeabilized with 0.1%
Triton X-100. After blocking of nonspeciﬁc sites with 5% normal
donkey serum, the cells were incubated for 2 h in the presence of
goat-raised anti–cAMP-GEFII/anti-EPACII (C-19, 1:50, Santa
Cruz Biotechnology, Inc.) and a guinea-pig polyclonal antiinsu-
lin antibody (B 65–1, 1:500, Euro-diagnostica). Anti–goat Cy3
and anti–guineapig Cy5 (Jackson ImmunoResearch Laborato-
ries) were then used to label the detected sites. Images were ac-
quired using the 543-nm (Cy3) and 633-nm (Cy5) lines of a
ZEISS 510 LSM confocal microscope. Emitted light was visual-
ized using a 63
 
 
 
/1.3 NA oil objective and a bandpass ﬁlter (565–
 
*
 
Abbreviations used in this paper:
 
 IRP, immediately release pool; ODN,
oligodeoxynucleotide.T
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615 nm; Cy3) or a 
 
 
 
650-nm ﬁlter (Cy5). The samples were
scanned sequentially with the appropriate settings to minimize
crosstalk.
 
Insulin Measurements
 
Islets were preincubated in Earle’s balanced Salt Solution (EBSS;
Invitrogen) containing 0.1% BSA and 2.8 mM glucose for 30 min
at 37
 
 
 
C. Batches of ﬁve islets were subsequently incubated for 90
min at 37
 
 
 
C in EBSS supplemented with 0.1% BSA, 2.8 or 20 mM
glucose and the respective test compound added. The incuba-
tion was terminated by placing the islets on ice. The supernatant
was removed and stored at 
 
 
 
20
 
 
 
C pending the insulin measure-
ments (ELISA). Forskolin was included at a concentration of 10
 
 
 
M in the experiments involving intact islets (rather than the 2
 
 
 
M used for the single-cell studies) to overcome any diffusion
barriers within the intact islet to ensure that exocytosis in B-cells
in the islet core is also stimulated.
 
Measurements of Islet cAMP
 
Groups of 10 islets were preincubated at 37
 
 
 
C in Krebs-Ringer bi-
carbonate buffer containing 115 mM NaCl, 4.7 mM KCl, 2.6 mM
CaCl
 
2
 
, 1.2 mM KH
 
2
 
PO
 
4
 
, 1.2 mM MgSO
 
4
 
, 20 mM NaHCO
 
3
 
, 16
mM HEPES, 2 mg/ml BSA, and 1 mM IBMX for 1 h and incu-
bated for another 15 min in same buffer with or without GLP-1
and forskolin. The reaction was stopped by addition of 50 mM
HCl and neutralized with NaOH. Concentration of cAMP was de-
termined by a cAMP [
 
125
 
I] scintillation proximity assay (Amer-
sham Biosciences).
 
Measurements of Granular Cl
 
 
 
 Uptake
 
Changes in insulin granular Cl
 
 
 
-ﬂuxes or pH (Figs. 9, C–E, and
10) were monitored by confocal imaging of LysoSensor
 
TM
 
Green
DND-189
 
®
 
 (LSG; Molecular Probes) ﬂuorescence as described
previously (Barg et al., 2001a; Renström et al., 2002b). LSG (1
 
 
 
M) was added during the last 30 min of cell culture and was in-
cluded in extracellular buffer that continuously superfused the
cells. LSG ﬂuorescence was excited using the 488-nm line of a
ZEISS 510 confocal microscope. The emitted light was collected
with a 63
 
 
 
/1.3 NA oil objective and a 
 
 
 
505-nm ﬁlter. Laser scan-
ning was performed with low pixel resolution (128 
 
 
 
 128) and
with 6-s intervals to minimize photobleaching. After giga-seal for-
mation, it was ascertained that LSG ﬂuorescence was stable for
 
 
 
30 s before the standard whole-cell conﬁguration was estab-
lished. The holding potential was set to 
 
 
 
70 mV and the temper-
ature held at 20
 
 
 
C to prevent exocytosis (Renström et al., 1996)
and concomitant cell swelling. Prior to experiments using Rp-
cAMPS, the dishes were pretreated with the membrane-per-
meant analogue 8-Br-Rp-cAMPS (0.5 mM), which did not inter-
fere with LysoSensorGreen loading. Under the experimental
conditions used (0.1 mM of the protonophore CCCP), stimula-
tion of Cl
 
 
 
 ﬂux is reﬂected as a reduction of LSG ﬂuorescence.
In Fig. 9, C–E, tolbutamide-induced changes in intragranular pH
in intact cells were estimated using the same method. To prevent
tolbutamide from eliciting exocytosis, with resultant loss of LSG
ﬂuorescence, a Ca
 
2
 
 
 
-free extracellular solution containing (in
mM) 138 NaCl, 5.6 KCl, 1.2 MgCl
 
2
 
, 5 HEPES, 5 glucose, and 0.2
 
 
 
M EGTA (pH 7.4 with NaOH) was used for these experiments.
 
PCR
 
Total mouse islet RNA from wild-type and SUR1
 
 
 
/
 
 
 
 mice was iso-
lated using RNeasy Mini Kit (QIAGEN). 1 
 
 
 
g of total RNA was
used for reverse transcription using random hexamer primers
and Superscript II (Invitrogen). In a negative control, Super-
script II was omitted from the reaction. PCR was performed un-
 
der the following conditions: 3 min at 94
 
 
 
C followed by 35 cycles
of 45 s at 94
 
 
 
C, 45 s at 58
 
 
 
C, and 45 s at 72
 
 
 
C with primers:
Rim2 sense: 5
 
 
 
GCTCAAACAAGGTTATGTGGGTG3
 
 
 
; Rim2 anti-
sense: 5
 
 
 
CCTGTCTTGTGAGCCCATGAGC3
 
 
 
; cAMPGEFII sense:
5
 
 
 
GGAGGAGAAAAGGTGGTGCT3
 
 
 
; and cAMPGEFII antisense:
5
 
 
 
CTCTCAAACTCCGCATAGAAC3
 
 
 
.
 
Data Analysis
 
The kinetic model used for ﬁtting experimental data (in Figs.
1–3 and 7) considers two pools of granules; the pool of immedi-
ately releasable granules (P) and the pool of fused granules (P
 
1).
Release can then be described as
(1)
where k is
(2)
The pool dynamics is described by the differential equation
(3)
Solutions to Eq. 3 were ﬁt to the experimental data and the ini-
tial size of P ( Cm,∞), taken to represent the immediately releas-
able pool (IRP), and the values of   were thus estimated. The
constant  0 describes the decay rate of P, which varies between in-
dividual experiments and depended on the initial pool size. A
power function was used to account for the fact that the capaci-
tance increase occurred after a delay and is consistent with the
idea that the effect of Ca2  on exocytosis in B-cells (Barg et al.,
2001b) as well as other secretory cells (Thomas et al., 1993; Hei-
nemann et al., 1994) exhibits great cooperativity. Tentatively, the
time constant   represent the sequential binding of Ca2 -ions to
the Ca2 -sensor of secretion. A third power yielded the best re-
sults and suggest that a minimum of three Ca2  ions are involved.
All data are quoted as mean values   SEM of indicated num-
ber of experiments. Statistical signiﬁcance was evaluated using
Student’s t test.
RESULTS
Stimulation of Exocytosis by GLP-1
We have reported previously that the incretin hormone
GLP-1 and agents that increase intracellular cAMP lev-
els such as the adenylate cyclase activator forskolin
stimulate exocytosis in insulin-secreting mouse B-cells
by both PKA-dependent and -independent mechanisms
(Ämmälä et al., 1993; Gromada et al., 1997; Renström
et al., 1997). Here we explored how GLP-1 affects the
kinetics of exocytosis by applying progressively longer
depolarizations (5–850 ms) from  70 to 0 mV before
(Fig. 1 A) and 4 min after addition of 10 nM of the hor-
mone (Fig. 1 B). The experiments were performed in
metabolically intact cells using the perforated patch
method. The relationships between pulse length and
the amplitude of the exocytotic response in the ab-
sence and presence of GLP-1 are summarized in Fig. 1
C. It can be seen that whereas the amplitude of the exo-
P
k
→P1,
k 1 e
t τ ⁄ – – ()
3
α0. =
dP
dt
------ kP. – =T
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cytotic responses increased with pulse length for short
depolarizations, the responses plateaued during depo-
larizations  200 ms. A secondary acceleration was ob-
served during long depolarizations in the presence of
GLP-1, but not in the absence of the hormone. The so-
lution of Eq. 3 was approximated to the data points to
derive the size of the IRP ( Cm,∞). The mean values of
seven paired experiments are given in Table I (lines 1
and 2). It is clear that GLP-1 increased IRP 2.3-fold.
This enhancement occurred without any effect on the
kinetics of exocytosis and the   averaged 48   18 ms
and 35   17 ms in the absence and presence of GLP-1,
respectively. Application of the adenylate cyclase activa-
tor forskolin (2  M) mimicked the effects of GLP-1 on
the size of IRP (Table I, line 3).
Effects of cAMP and PKA Inhibition during Standard
Whole-cell Recordings
We proceeded to study the effects of cAMP and Rp-
cAMPS (a blocker of cAMP-dependent activation of
PKA) on exocytosis. The experiments were conducted
using the standard whole-cell conﬁguration, in which
the electrode solution dialyzes the cell interior allowing
control of the composition of the cytosol. Fig. 2 shows
exocytotic responses in three different cells elicited by
progressively longer voltage-clamp depolarizations un-
der control conditions (A), in the presence of 0.1 mM
cAMP (B) and in the simultaneous presence of 0.1 mM
cAMP and 0.5 mM of Rp-cAMPS (C). Under control
conditions, the exocytotic responses were small and
plateaued after a capacitance increase of  20 fF (Fig. 2
A). Inclusion of 0.1 mM cAMP in the intracellular solu-
tion exerted a strong stimulatory effect that was detect-
able already during brief stimuli (Fig. 2, B and C) and
longer depolarizations elicited progressively larger exo-
cytotic responses. Interestingly, the effect of cAMP was
only partially suppressed by Rp-cAMPS and the capaci-
tance increase elicited by  250-ms depolarizations was
the same in the absence and presence of the PKA-
inhibitor (Fig. 2, C and D). We have demonstrated else-
where that the effects of Rp-cAMPS are identical to
those of the peptide inhibitor PKI (Renström et al.,
1997), making it likely that the observed effects of Rp-
cAMPS do indeed reﬂect PKA inhibition.
The relationships between pulse length and the mag-
nitude of the exocytotic responses under control condi-
tions, with an intracellular cAMP concentration of 0.1
mM and in the simultaneous presence of cAMP and
Rp-cAMPS are summarized in Fig. 2 D. Solutions to Eq.
3 were approximated to the data points and the aver-
age size of IRP determined under the different experi-
mental conditions is presented in Table I (lines 4, 8,
and 10). Cyclic AMP produced a 15-fold increase of IRP
that was only partially reversed by Rp-cAMPS. The ca-
pacitance increase plateaued during depolarizations
lasting  200 ms with a secondary stimulation being ob-
served during longer depolarizations under both con-
trol conditions and in the presence of cAMP (50 fF/s
under control conditions and 300 fF/s in the presence
of cAMP). The latter component of capacitance in-
crease was highly sensitive to inclusion of Rp-cAMPS
and the  C/ t-value in fact assumed a negative value
in the presence of the PKA-inhibitor ( 30 fF/s; i.e.,
less than what was observed under control conditions
in the absence of cAMP), possibly indicative of endocy-
tosis. These experiments conﬁrm our earlier observa-
tion that cAMP stimulates exocytosis by both PKA-
dependent and -independent mechanisms and provide
the novel observation that the PKA-independent action
is particularly prominent during brief depolarizations.
Control experiments using 0.5 mM Rp-cAMPS alone re-
Figure 1. GLP-1 potentiates exocytosis in B-cells. Increases in
cell capacitance ( Cm, bottom trace) elicited by progressively
longer (5, 10, 15, 30, 50, 100, 150, 250, 350, 450, and 850 ms) depo-
larizations from  70 to 0 mV (V, top trace) under (A) control con-
ditions and (B) 4 min after the inclusion of 10 nM GLP-1 in the ex-
tracellular medium. The interval between two successive depolar-
izations was 15 s for pulses  50 ms and 30 s for longer pulses. For
clarity, only responses to the 30-, 100-, 250-, and 450-ms depolariza-
tions are shown. The recording was performed using the perfo-
rated patch conﬁguration. (C) Relationship between pulse dura-
tion (t) and increase in cell capacitance ( Cm) under control con-
ditions and in the presence of 10 nM GLP-1 as indicated. The
curves were derived by ﬁtting Eq. 3 to the data points for depolar-
izations  350 ms. The dotted lines represent linear ﬁts to the val-
ues measured in response to the two longest depolarizations. Data
are mean values   SEM of seven paired experiments. *P   0.05
and **P   0.01.T
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vealed that the compound did not exert any stimula-
tory effect on its own (Fig. 2 D).
Differential cAMP Dependence of PKA-dependent
and -independent Stimulation of Exocytosis
We subsequently investigated the cAMP dependence of
the PKA-dependent and -independent actions on exo-
cytosis. Cyclic AMP was applied intracellularly at con-
centrations of 0, 1, 10, 50, 100, and 500  M. The data
are summarized in Fig. 3 A. Solutions of Eq. 3 were ap-
proximated to the data points and the values of Cm∞
and   C/ t450–850 are presented in Table I. Fig. 3 B
shows the normalized increase in IRP (S) against the
cAMP concentration (the increase in IRP at 500  M of
cAMP taken as unity). The Hill equation
(4)
was ﬁt to the data points to derive the Hill coefﬁcient
(n) and the Kd value, the concentration of cAMP at
which stimulation is half-maximal (Kd). In Eq. 4, Smax
represent the calculated maximal cAMP-induced stimu-
lation. We thus obtained a Kd value of 29  M. For com-
parison, the normalized response seen in the presence
of 0.1 mM cAMP and 0.5 mM Rp-cAMPS is shown (open
circle). It is clear that the early cAMP-dependent com-
ponent of exocytosis is little affected by PKA-inhibition.
The effects of varying the intracellular concentration
of cAMP on exocytosis elicited by trains of 10 500-ms
depolarizations from  70 to 0 mV (Fig. 3 C) were ana-
lyzed similarly. The total increase in cell capacitance
elicited by the train in the absence of cAMP is quite
SS max∗ cAMP []
n
Kd cAMP []
n +
------------------------------------



, =
variable but in this series of experiments averaged 31  
4 fF (n   6). A low concentration of cAMP (1  M) only
marginally stimulated exocytosis, but much larger re-
sponses were obtained after inclusion of  10   M
cAMP in the pipette solution. Fig. 3 D summarizes the
amplitude of the capacitance increases elicited by the
last nine pulses of the train at the different concentra-
tions of cAMP (1–500  M). The Kd value for this late
component was estimated to 6  M by approximating
the data to Eq. 4. Unlike what was observed for the
rapid component (Fig. 3 B), the late cAMP-dependent
effect was highly sensitive to Rp-cAMPS and in the pres-
ence of this antagonist, the increase in cell capacitance
elicited by the last nine pulses was in fact less than that
observed in the complete absence of cAMP (Fig. 3 D,
open circle).
cAMP Mediates its PKA-independent Component via
cAMP-GEFII
The cAMP-binding protein cAMP-GEFII binds cAMP at
concentrations  10  M and has been reported to me-
diate PKA-independent effects of the nucleotide on in-
sulin secretion (Ozaki et al., 2000). We next conﬁrmed
that this effect also contributes to the cAMP-induced
enhancement of exocytosis monitored as increases in
membrane capacitance using the perforated patch
whole-cell conﬁguration (Fig. 4, A and B). The PKA-
dependent effects were prevented by pretreatment of
the cells with 500  M of the membrane-permeant PKA
inhibitor 8-Br-Rp-cAMPS. After pretreatment with con-
trol oligonucleotide, exocytosis elicited by a 500-ms de-
polarization from  70 to 0 mV applied in the presence
TABLE 1
Summary of the Effects of cAMP and PKA Inhibition in B-cells from Wild-type and SUR1 /  Mice
Line Condition  Cm,∞ ( IRP)  Cm/ t450–850 n
fF fFs 1
Wild-type B-cells
Perforated patch
 1 Control 45   76     8 7
 2 GLP-1 (10 nM) 104   15a 56   17a  7
 3 Forskolin (2 mM) 123   30a 152   58a 11
Wild-type B-cells
Standard whole-cell
 4 Control 11   2 25   12  7
 5 cAMP (1  M) 18   6 16   4 6
 6 cAMP (10  M) 57   10c 150   55b  5
 7 cAMP (50  M) 83   20c 94   18b  5
 8 cAMP (100  M) 157   27c 317   119b  7
 9 cAMP (500  M) 176   38c 306   135b  6
 10 cAMP (100  M) and Rp-cAMPS (0.5  M) 96   26  39   35d  7
SUR1 /  B-cells
Standard whole-cell
 11 Control 16   6 43   19  5
 12 cAMP (0.1  M) 68   18e,f 77   40  8
 13 cAMP (0.1  M) and Rp-cAMPS (0.5  M) 18   3g 3   10g  6
The size of IRP was estimated from the approximation of the solution of Eq. 3 to the data points in Figs. 1 C, 2 D, and 7, D and E.  Cm/ t450–850 is the rate
of capacitance increase occurring between 450- and 850-ms data points. Data are mean values   SEM of indicated number of cells tested. Statistical
significances refer to comparisons within the same column.
aP   0.01 versus line 1; bP   0.01 versus line 4; cP   0.05 versus line 4; dP   0.02 versus line 8; eP   0.05 versus line 11; fP   0.05 versus line 8; gP   0.05
versus line 12. T
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186 SUR1 and Exocytosis in Mouse Pancreatic B-cells
of forskolin amounted to 91   8 fF (n   5). This value
is about twice that measured in cells pretreated with an-
tisense cAMP-GEFII oligonucleotide, which averaged
48   5 fF (n   5; P   0.01). Exocytosis in the presence
of Rp-cAMPS alone amounted to 5   5 fF (n   5) and
10   4 (n   5) after pretreatment with control and an-
tisense ODNs, respectively. We conclude that cAMP-
GEFII mediates  55% of the PKA-independent com-
ponent of exocytosis (i.e., 100% * {1   [48 fF   10 fF]/
[91 fF   5 fF]}).
The cAMP effector protein cAMP-GEFII was origi-
nally identiﬁed by two-yeast hybrid screening of a
MIN6-cell library using the sulfonylurea receptor
SUR1 as the bait (Ozaki et al., 2000). We have re-
ported previously that sulfonylureas, such as tolbuta-
mide and glibenclamide, stimulate exocytosis by a
late effect on the exocytotic machinery that does not
involve closure of plasma membrane KATP channels
and that culminates in accelerated priming of the
secretory granules by a PKC-dependent mechanism
(Eliasson et al., 1996; Barg et al., 1999, 2001a). We
analyzed the signiﬁcance of cAMP-GEFII for sulfo-
nylurea-stimulated exocytosis using clonal MIN-6 cells.
In control cells (pretreated with control oligonucle-
otides or untransfected cells, no difference being ob-
served between the two sets of cells), the capacitance
increased steadily after establishment of the whole-
cell conﬁguration at a rate ( C/ t) of 9   1 fF/s
(n   17; Fig. 4 C). Inclusion of 0.1 mM cAMP in the
pipette solution almost doubled the rate of exocytosis
and the  C/ t-value rose to 17   2 fF/s (n   18, P  
0.001 vs. control). Addition of tolbutamide (0.1 mM)
produced a further 30% stimulation of exocytosis
and  C/ t amounted to 22   1 fF/s (n   13; P  
0.05 vs. rate measured with cAMP alone). When the
same type of experiment was repeated in cells pre-
treated with antisense cAMP-GEFII oligonucleotides
(Fig. 4 D),  C/ t averaged 12   3 fF/s (n   12) un-
der control conditions, 16   3 fF/s (n   14) in the
presence of cAMP alone and 14   3 fF/s in the simul-
taneous presence of cAMP and tolbutamide (n   14;
P   0.05 vs. rate observed in cells exposed to cAMP
and tolbutamide but incubated with the control oli-
gonucleotide). Thus, reduced expression of cAMP-
GEFII not only abolished the effect of cAMP on
exocytosis, it also interfered with the ability of tol-
butamide to stimulate exocytosis. This conclusion is
reinforced by experiments performed in MIN-6 cells,
which had been transfected with a dominant-negative
mutant of cAMP-GEFII (G114/G422D; Ozaki et al.,
2000; Fig. 4 E). In this series of experiments,  C/ t
averaged 8   2 fF/s (n   16) under control condi-
tions, 8   1 fF/s (n   15) in the presence of cAMP
alone and 8   2 fF/s in the simultaneous presence of
cAMP and tolbutamide (n   13). The effects of treat-
ment with the antisense oligonucleotide on exocyto-
sis echo those on cAMP-GEFII immunoreactivity (Fig.
4 F). Whereas both MIN6-cells and primary mouse
B-cells treated with the control oligonucleotide ex-
Figure 2. Kinetics of cAMP-stimulated exocytosis. (A) As in Fig.
1 but recordings were performed using the standard whole-cell
conﬁguration and the cells were dialyzed with standard cAMP-free
intracellular solution. The recording commenced  1 min after es-
tablishment of the whole-cell conﬁguration to allow complete
equilibration of the pipette solution with the cytoplasm. (B) As in
A but cAMP was included at a concentration of 0.1 mM. (C) As in
B but 0.5 mM of the PKA-inhibitor Rp-cAMPS was added to the pi-
pette solution. (D) Relationship between pulse duration (t) and
increase in cell capacitance ( Cm) under control conditions, in
the presence of 0.1 mM cAMP, in the simultaneous presence of 0.1
mM cAMP and 0.5 mM Rp-cAMPS and in the presence of 0.5 mM
Rp-cAMPS alone as indicated. Data are mean values   SEM of
5–10 experiments. aP   0.05 and bP   0.01 for comparison between
cAMP and control. cP   0.05 for comparison of cAMP alone with
the combination of cAMP and Rp-cAMPS; dP   0.05 for compari-
son of control with the combination of 0.1 mM cAMP and 0.5 mM
Rp-cAMPS. Note that intracellular cAMP enhances both an early
and a late component of exocytosis and that Rp-cAMPS principally
affects the late component.T
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187 Eliasson et al.
hibited clear cAMP-GEFII/EPACII immunoreactivity,
that only weakly colocalized with insulin, cells treated
with the antisense oligonucleotide showed little cAMP-
GEFII immunoreactivity. Notably, the antisense treat-
ment did not affect insulin immunoreactivity.
A Selective cAMP-GEFII Agonist Promotes Rapid Exocytosis
The data of Fig. 4 suggest that cAMP-GEFII is responsible
for the PKA-independent component of cAMP-stimu-
lated exocytosis. We next tested the effects of the selec-
tive cAMP-GEFII agonist 8CPT-2Me-cAMP on B cell exo-
cytosis. Secretion was elicited by a train of 10 depolariza-
tions from  70 to 0 mV under control conditions, in the
presence of 0.1 mM 8CPT-2Me-cAMP alone and in the si-
multaneous presence of both the agonist and 0.5 mM
Rp-cAMPS (Fig. 5 A). The total increase in capacitance
elicited by the train averaged 99   14 fF (n   6) under
control conditions, 274   51 fF (n   6; P   0.01 vs. con-
trol) in the presence of 0.1 mM 8CPT-2Me-cAMP and
178   30 fF (n   5) in the simultaneous presence of 0.1
mM 8CPT-2Me-cAMP and 0.5 mM Rp-cAMPS. The latter
value is statistically different from the control value (P  
0.05) but not from that observed in the presence of
8CPT-2Me-cAMP alone. Fig. 5 B illustrates the increase in
cell capacitance elicited by the individual pulses during
the train. It is clear that the action of 8CPT-2Me-cAMP is
particularly pronounced during the ﬁrst part of the train
and that this effect was unaffected by PKA-inhibition
(pulses 1 and 2). Surprisingly, an exocytotic component
sensitive to Rp-cAMPS was observed during the middle
Figure 3. Concentration dependence of cAMP-induced stimulation of secretion. (A) As in Fig. 2 but the cells were infused with intracel-
lular medium containing 0 (white square), 1 (light gray triangle), 10 (light gray circle), 50 (gray diamond), 100 (dark gray square), and
500  M cAMP (black triangle). The curves were obtained by approximating Eq. 3 to the data points. Data are mean values   SEM of 5–9
experiments. (B) Normalized size of cAMP-induced increase in IRP ([ Cm    Cm,basal]/[ Cm,500    Cm,basal], where  Cm,basal,  Cm, and
 Cm,500 are the calculated values of IRP in the absence of cAMP at a given cAMP concentration and in the presence of 500  M cAMP, re-
spectively (left axis), and the absolute values of IRP (right axis) displayed against the intracellular [cAMP]. The curve shown was derived
by approximating Eq. 4 to the normalized mean values. The open circles represents the amplitude of IRP observed in the simultaneous
presence of 0.1 mM cAMP and 0.5 mM Rp-cAMPS. (C) Exocytotic responses elicited by trains consisting of ten 500-ms depolarization from
 70 to 0 mV in the presence of 0, 1, 10, 50, 100, and 500  M cAMP. (D) As in B but the summed increase in cell capacitance evoked by the
last nine pulses ( ) of the train was analyzed. The open circle represents   in the simultaneous presence of 0.1 mM
cAMP and 0.5 mM Rp-cAMPS. Data are mean values   SEM of 4–6 experiments.
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188 SUR1 and Exocytosis in Mouse Pancreatic B-cells
part of the train (pulses 3–5). We speculate that Ca2 -
entry associates with some Ca2 -dependent activation of
adenylate cyclase leading to sufﬁcient generation of
cAMP to promote granule mobilization by the PKA-
dependent mechanism (Fig. 3 D). This scenario would
also explain the slow increase in capacitance that occurs
in the complete absence of cyclic AMP (Figs. 3 C and
5 A) and that can likewise be suppressed by Rp-cAMPS
(Figs. 2 C and 3 D; Renström et al., 1997).
Impaired Insulinotropic Action of Glucose and
the Incretin GLP-1 in vitro
It has been reported recently that insulin secretion
from SUR1 knockout mice (SUR1 / ) exhibits a much
lower sensitivity to intracellular cAMP and appears un-
affected by stimulation with incretins (Shiota et al.,
2002; Nakazaki et al., 2002). We have repeated these ex-
periments focusing on the ability of GLP-1 and forsko-
lin to stimulate glucose-induced insulin secretion and
the effects of inhibiting PKA using Rp-cAMPS in wild-
type and SUR1 /  islets (Table II). Wild-type islets had
low basal insulin secretion, which increased ﬁve- to
ninefold in response to stimulation with 1  M glib-
enclamide or 20 mM glucose. GLP-1 and forskolin po-
tentiated the stimulatory action of glucose 2.8- to 3.6-
fold. The latter effects were partially (65–70%) coun-
teracted by Rp-8-Br-cAMPS. In islets from SUR1 / 
mice, basal secretion was increased  1.4-fold relative to
Figure 4. Antisense cAMP-GEFII
abolishes cAMP- and sulfonylurea-
induced secretion. (A and B) Increase
in cell capacitance ( Cm, lower trace)
elicited by a 500-ms depolarization
from   70 to 0 mV. The experiments
were conducted on B-cells prepared
from islet pretreated for 72 h with 4  M
control (A) or antisense cAMP-EGFII
ODNs (B). Experiments were con-
ducted in the presence of 10  M Rp-
cAMPs alone (left) and in the simulta-
neous presence of 2–10  M forskolin
and 10  M Rp-cAMPS (right). (C) Ca-
pacitance increases recorded from
MIN6-cells during standard whole-cell
recordings when the cells were infused
with a buffer containing  1.5  M free
Ca2  under control conditions (black
trace) and in presence of 0.1 mM cAMP
(red trace) or 0.1 mM cAMP and 0.1
mM tolbutamide (blue trace). The cells
had been cultured for 96 h with control
oligodeoxynucleotides. (D) As in C but
cells had been cultured for 96 h with
antisense cAMP-GEFII. (E) As in C but
the cells had been transfected with the
cAMP-GEFII mutant G114E/G422D
 36 h before the experiments. (F)
Distribution of insulin (red) and cAMP-
GEFII (EPAC) immunoreactivity (green)
in MIN-6 and primary B-cells under
control conditions and when the cells
had been cultured with anti-sense
cAMP-GEFII. Bar, 10  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y
189 Eliasson et al.
that seen in wild-type islets. As expected, glibenclamide
had no effect but glucose retained a 4.5-fold stimula-
tory action. GLP-1 and forskolin potentiated glucose-
induced secretion from SUR1 /  islets 2.2- to 2.8-fold;
i.e., not much less than the relative stimulation in wild-
type islets. The same observations were made in two
separate experimental series. However, unlike the situa-
tion in the wild-type islets, the effects of forskolin and
GLP-1 were fully ( 90%) antagonized by Rp-cAMPS.
The smaller secretory responses in SUR1 /  B-cells are
not attributable to degranulation and islet insulin con-
tent averaged 280   10 ng insulin/islet (n   6) and
253   10 ng/islet (n   6) in wild-type and SUR1 / 
mice, respectively. GLP-1 increased cAMP content
more than than sevenfold in SUR1 /  islet; similar to
the ninefold elevation seen in the wild-type islets (Fig.
6). The effects of GLP-1 were dose-dependent and bell-
shaped in both wild-type and SUR1 /  islets. The maxi-
mum cAMP levels were observed at 10 nM and at this
concentration the content approached the values ob-
served in response to 10  M forskolin.
Lack of an Early PKA-independent Component in B-cells
from SUR  /  Mice
Fig. 7, A–C, shows the effects of intracellular cAMP and
PKA inhibition on exocytosis measured as a capacitance
increase in B-cells from SUR1 /  mice using the same
protocol as in Fig. 2. Under basal conditions (no cAMP,
Fig. 7 A), the exocytotic responses were small and  20 fF
for depolarizations lasting 450 ms. As was the case in
wild-type B-cells, inclusion of 0.1 mM cAMP in the intra-
cellular medium resulted in much larger exocytotic re-
sponses (Fig. 7 B). However, unlike the situation in wild-
type B-cells, the effects of cAMP were fully antagonized
by 0.5 mM Rp-cAMPS (compare Figs. 2 C and 7 C). The
relationships between pulse length and exocytosis under
control conditions, in the presence of cAMP and in the
simultaneous presence of both cAMP and Rp-cAMPS are
summarized in Fig. 7 D. The size of IRP under the differ-
ent experimental conditions was determined by ﬁtting
Eq. 3 to the observed data points (Table I, lines 11–13).
It is apparent that cAMP produced a fourfold increase in
pool size but that it is  90 fF smaller than in wild-type
animal (compare lines 8 and 12 of Table I). The effect of
cAMP in B-cells from SUR1 /  mice, unlike what was ob-
served in their wild-type counterparts, was completely in-
hibited by Rp-cAMPS. Moreover, the fast component of
exocytosis (detectable during the ﬁrst 100 ms) was more
prominent in wild-type than in SUR1 /  islets (Fig. 7 E).
Thus, the value of   (see Eq. 2) was 3.5-fold higher in
B-cells from SUR1 /  mice than in their wild-type coun-
terparts (45   13 ms vs. 12   4 ms; P   0.05). We can
discard the possibility that the differences between wild-
type and SUR1 /  B-cells were due to a reduction of
voltage-gated Ca2 -entry. The Ca2 -current amplitude
during depolarizations to 0 mV averaged  57   5 pA
Figure 5. PKA-independent stimula-
tion of exocytosis by the cAMP-GEFII–
selective agonist 8CPT-2Me-cAMP. (A)
Capacitance increases (bottom) elicited
by trains of 10 depolarizations from
 70 to 0 mV (top) under control con-
ditions (left), in the presence 100  M
8pCPT-2Me-cAMP (middle) and in the
simultaneous presence of the agonist
and 0.5 mM Rp-cAMPs. (B) Mean
increase in membrane capacitance
( Cm,n    Cm,n   1) during each individ-
ual depolarization of the train (n). Data
are mean values   SEM of 5–6 experi-
ments. aP   0.05, bP   0.001, and cP  
0.01 for comparison between 8CPT-
2Me-cAMP and control. dP   0.01 and
eP   0.05 for comparison between the
combination of 8CPT-2Me-cAMP and
Rp-cAMPS and control. fP     0.05 for
comparision between 8CPT-2Me-cAMP
and the combination of 8CPT-2Me-
cAMP and Rp-cAMPS.T
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190 SUR1 and Exocytosis in Mouse Pancreatic B-cells
(n   12) and  64   8 pA (n   8) in SUR1 /  and wild-
type B-cells, respectively.
cAMP-GEFII and Rim2 are Transcribed in SUR1 /  B-cells
We tested whether the failure of cAMP to exert a
PKA-independent stimulatory action on exocytosis in
SUR1 /  B-cells results from loss of transcription of the
putative effector proteins. However, applying RT-PCR
to islets isolated from SUR1 /  mice indicate that both
cAMP-GEFII and Rim2 remain expressed in islets from
the knockout animals (Fig. 8).
Sulfonylureas Stimulate Exocytosis in B-cells from SUR1 /  Mice
It has been suggested that sulfonylureas stimulate exo-
cytosis in B-cells by a direct effect on the exocytotic ma-
chinery (Eliasson et al., 1996). We investigated whether
this effect is retained in SUR1 /  B-cells using a Ca2 -
infusion protocol (intracellular solution II supple-
mented with 0.1 mM cAMP). In SUR1 /  B-cells, tol-
butamide (0.1 mM) increased the rate of capacitance in-
crease  2.5-fold at both 0.17 and 1.5  M intracellular
free Ca2  (Fig. 9, A and B); from 5   1 fF/s (n   8) to
14   3 fF/s (n   11; P   0.05) at low Ca2  and from
16   3 fF/s (n   6) to 37   9 fF/s (n   6; P   0.05) at
the higher intracellular Ca2 -concentration (Fig. 9, A
and B). These rates and the extent of stimulation are
comparable to effects reported previously (Barg et al.,
1999, 2001a). The failure of glibenclamide to stimulate
insulin secretion in B-cells from SUR1 /  mice (Table
II) we attribute to the glucose concentration in this se-
ries of experiments. The direct action of sulfonylureas
TABLE II
Insulin Release (ng/islet/h)
Line Conditions Wild-type (SUR1 / ) Knockout (SUR1 / )
1 2.8 mM glucose 0.27   0.04(n   5) 0.39   0.06 (n   5)i
2 2.8 mM glucose
 1  M glibenclamide
1.34   0.10 (n   5)a 0.41   0.09 (n   5)k
3 20 mM glucose 2.53   0.23 (n   5)b,c 1.76   0.27 (n   5)a,c,k
4 20 mM glucose
10 nM GLP-1
7.01   0.51 (n   5)d 3.87   0.37 (n   5)g,j
5 20 mM glucose
10 nM GLP-1
 100  M Rp-8-Br-cAMPS
4.11   0.33 (n   5)e 1.91   0.31 (n   5)e,j
6 20 mM glucose
 10 mM forskolin
8.97   0.62 (n   5)d 4.88   0.49 (n   5)d,i
7 20 mM glucose
 10 mM forskolin
 100  M Rp-8-Br-cAMPS
4.54   0.46 (n   5)f 2.07   0.43 (n   5)h
Impaired PKA-independent incretin effect in islet from SUR1 /  mice. Secretion of insulin from isolated islets taken from wild-type (SUR1 / ) and SUR1
knockout (SUR1 / ) in the absence and presence of different insulin secretagogues and inhibitors. Incubation was performed with five islets in each tube
and at either 2.8 or 20 mmol/l glucose. Data are presented as mean values   SEM of indicated number of experiments (n). 
aP   0.01 versus line 1; bP   0.001 versus line 1; cP   0.02 versus line 2; dP   0.001 versus line 3; eP   0.01 versus line 4; fP   0.001 versus line 6; gP   0.01
versus line 3; hP   0.01 versus line 6; iP   0.001; jP   0.01 versus corresponding value in wild-type islets; kP   0.05 versus corresponding value in wild-type
islets. 
Figure 6. GLP-1–induced cAMP production in wild-type and
SUR1 /  B-cells. The amount of cAMP generated was measured
in wild-type and SUR1 /  B-cells as indicated at 0–100 nM GLP-
1. Values observed in the presence of 10  M forskolin have
been included for comparison. Data are mean values   SEM of
six experiments in each group. All values in the presence of
GLP-1 are statistically different from control value (P   0.001;
not shown). *P   0.05 for the comparison between wild-type
and SUR1 /  islets.
on exocytosis is particularly pronounced at high glu-
cose, whereas it is without effect at low concentrations
of the sugar (unpublished data).
Acidiﬁcation of the granule interior has been identi-
ﬁed as an important reaction in the preparation of the
granules for release (Barg et al., 2001a; Renström et al.,
2002a,b). As shown in Fig. 9 C, extracellular applica-T
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tion of tolbutamide resulted in a pronounced acidiﬁca-
tion of the granules (detected as an increase in granu-
lar LSG ﬂuorescence), an effect that was maintained in
B-cells from SUR1 /  mice (Fig. 9 D), although the av-
erage effect was reduced by  30% (Fig. 9 E). Appar-
ently, the ability of tolbutamide to promote granule
priming is largely unperturbed by ablation of SUR1.
Cyclic AMP Stimulates Inﬂux of Cl  by a PKA-independent 
Mechanism in Wild-type but Not in SUR1 /  B-cells
ClC3 channels have been shown previously to play an
important role in granule priming by providing the
shunt conductance required for the granules to acidify
(Barg et al., 2001a; Renström et al., 2002a). Given that
the stimulatory effects of both the PKA-independent
mechanism of cAMP and those of the sulfonylureas on
exocytosis appear to involve cAMP-GEFII (Fig. 4, C–E),
it is tempting to speculate that their actions converge
at the level of granular ClC3-channels. In wild-type
B-cells, inclusion of cAMP accelerated granule depro-
tonation (corresponding to stimulation of Cl  inﬂux)
fourfold over that seen under control conditions, an ef-
fect resistant to PKA inhibition (Fig. 10, A and C). In-
terestingly, the ability of cAMP to accelerate Cl  uptake
into the granules was almost abolished in B-cells from
SUR1 /  mice (Fig. 10, B and C) and the rate of ﬂuo-
rescence decrease was not signiﬁcantly different from
that observed in the absence of cAMP. We are not im-
plying that granules in B-cells from SUR1 /  mice are
unable undergo priming. Indeed the ability of Ca2 
alone to acidify the granules was the same in wild-type
and SUR1 /  B-cells (Fig. 10 C). It is evident from both
the capacitance measurements and insulin release ex-
periments that SUR1 /  B-cells contain a large pool of
release-competent granules. We postulate, however,
that the ability of cAMP to accelerate priming is much
reduced in the SUR1 /  B-cells and that this accounts
for the poor incretin effects in these cells.
Figure 7. SUR1 knockout mice lack PKA-independent component of cAMP-stimulated exocytosis. (A–C) As in Fig. 2, A–C but experi-
ments were performed on B-cells isolated from SUR1 knockout mice. (D) Relationship between pulse duration (t) and increase in cell ca-
pacitance ( Cm) under control conditions, in the presence of 0.1 mM cAMP, and in the simultaneous presence of 0.1 mM cAMP and 0.5
mM Rp-cAMPS. The curves were derived by approximating Eq. 3 to the data points for depolarizations  350 ms. The dashed lines connect
data point for depolarizations  350 ms and were derived by linear approximation. aP   0.05 for comparison between cAMP and control.
bP   0.05 for comparison of cAMP alone with the combination of cAMP and Rp-cAMPS. Data are mean values   SEM of 5–8 experiments.
(E) Exocytosis measured in the presence of 0.1 mM cAMP during depolarizations  100 ms in wild-type (data taken from Fig. 2 D) and in
SUR1 /  mice. Note slow onset of exocytosis in the knockout B-cells. **P   0.01.T
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DISCUSSION
The ability of cAMP-increasing agents to stimulate insu-
lin secretion is well established (Wollheim and Sharp,
1981), but the precise cellular processes involved are
not fully understood. Here we have combined measure-
ments of insulin release with high-resolution capaci-
tance measurements, antisense oligonucleotide tech-
nology, and the use of transgenic animals to dissect the
mechanisms by which cAMP accelerates exocytosis. We
conﬁrm that cAMP enhances insulin secretion by both
PKA-dependent and -independent mechanisms (Ren-
ström et al., 1997). The latter pathway involves the
cAMP effector protein cAMP-GEFII and, somewhat sur-
prisingly, requires the participation of the sulfonylurea
protein SUR1. Here we discuss in turn the properties of
PKA-dependent and -independent exocytosis, their re-
spective roles in insulin secretion and the possible in-
teraction of the PKA-independent mechanism of exocy-
tosis with the sulfonylurea receptor protein SUR1.
The PKA-dependent and -independent Mechanisms of
cAMP-stimulated Exocytosis Can Be Temporally Separated 
and Exhibit Distinct Concentration Dependence
Our data indicate that PKA-independent (Rp-cAMPS–
insensitive) effects of cAMP on exocytosis accounts for
a capacitance increase of  100 fF (at 0.1 mM cAMP)
that plateaus within  100 ms, whereas the PKA-depen-
dent (Rp-cAMPS–sensitive) component became appar-
ent during depolarizations  150 ms. (Figs. 2 D and 3,
B and D). We can discard the possibility that the rapid
component of capacitance increase reﬂects release of
GABA-containing synaptic-like microvesicles (SLMVs)
rather than insulin-containing granules as has previ-
ously been proposed for rat B-cells (Takahashi et al.,
1997). Using an assay that allows detection of single-ves-
icle release of GABA, we estimate that exocytosis of
SLMVs contribute only  1% of the total capacitance
increase (Braun et al., 2002).
The PKA-dependent and -independent mechanisms
of cAMP-stimulated exocytosis not only differ with re-
gard to speed (Figs. 2–3), they can also be distin-
guished by differences in their dose–response proper-
ties (Fig. 3). Whereas the PKA-dependent pathway ex-
hibits a Kd of 6  M, a ﬁvefold higher concentration is
required to activate the PKA-independent mechanism.
Previous data argue that the PKA-independent effects
are mediated by the cAMP-sensing protein cAMP-GEFII
(Ozaki et al., 2000; Kashima et al., 2001). Three obser-
vations corroborate this notion. First, treatment of is-
lets with antisense oligonucleotides against cAMP-
GEFII resulted in a marked reduction of PKA-indepen-
dent exocytosis (Fig. 4 A). Second, transfection of
MIN6-cells with a dominant mutant of cAMP-GEFII
(G114E/G422D; Fig. 4 E) abolished cAMP-stimulated
secretion. Third, inclusion of the speciﬁc cAMP-GEFII
agonist 8CTP-2Me-cAMP in the intracellular solution
mimicked the Rp-cAMPS-resistant component of cAMP-
induced secretion (Fig. 5).
We propose that the PKA-independent component
of exocytosis can be used to estimate the cAMP concen-
tration at the release sites. Under basal conditions, the
size of IRP amounted to 45 fF, which rose to  100 fF
and  120 fF after stimulation with 10 nM GLP-1 or 2
 M forskolin (Table I). Using the dose–response curve
in Fig. 3 B, these values correspond to a cAMP concen-
trations of 8, 42, and 70  M under basal conditions in
the presence of GLP-1 and after stimulation with for-
skolin. Thus, the cAMP concentration sensed by the
exocytotic machinery may vary by almost a factor of 10
under different experimental conditions. It is interest-
ing to compare the above concentrations with the re-
ported cAMP levels in the absence and presence of for-
skolin. In one study performed in the absence of any
phosphodiesterase inhibitor, the cAMP content of iso-
lated mouse islets was found to increase from a basal 4
fmol/islet to  65 fmol in the presence of 10  M for-
skolin (Eddlestone et al., 1985). The above values can
be converted to global intracellular cAMP concentra-
tions taking the intracellular water volume to be  2 nl
in mouse islets (Ashcroft et al., 1970). We thereby esti-
mate that cAMP increases from a basal concentration
of  2 to  30  M in the presence of forskolin. Since
Figure 8. RT-PCR analyses of Rim2 and cAMP-GEFII expression
in islets from wild-type and SUR1 /  mice. Expression proﬁles of
cAMP-GEFII and Rim2 ( ) in wild-type and SUR /  islets. In a
negative control reaction ( ), reverse transcriptase was omitted.
PCR products were analyzed on 1% agarose gels and bands of the
predicted size were obtained from Rim2 (262 bp) and cAMP-
GEFII (554 bp), after 35 ampliﬁcation cycles. Molecular weight
standard is shown to the right.T
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the latter value is only  40% of that suggested by the
capacitance measurements, it appears that fairly steep
intracellular gradients of cAMP may exist within the B
cell. This is perhaps not so unexpected given that ade-
nylate cyclase is situated in the plasma membrane, i.e.,
close to the release site. It is also worthy of note that al-
ready the basal concentration (2  M) is sufﬁcient to al-
low some limited PKA-dependent stimulation of gran-
ule mobilization (Fig. 3 D).
Evidence for PKA-dependent and -independent Components of 
Insulin Release in vitro in Wild-type and SUR1 /  mice
Although SUR1 /  B-cells lack functional KATP-chan-
nels, these islets retain some glucose dependence of in-
sulin secretion (3.5-fold stimulation; Table II). Con-
trary to what was reported recently by others (Nakazaki
et al., 2002), islets from SUR1 /  mice also respond
well to GLP-1 and forskolin although the magnitude of
the responses is only 50% of those seen in wild-type is-
lets. However, an important difference exists with re-
spect to the effects of PKA inhibition. Whereas 30–35%
of insulin secretion elicited by GLP-1 or forskolin is re-
sistant to Rp-cAMPS in wild-type islets, the PKA-inde-
pendent component is absent in the SUR1 /  islets.
Consistent with data reported by others (Nakazaki et
al., 2002), this difference cannot be explained by a re-
duced ability of GLP-1 and forskolin to increase intra-
cellular cAMP, which was only marginally reduced in
the knockout islets. Indeed, the lack of a rapid PKA-
independent component of insulin secretion was
confirmed using capacitance measurements in which
B-cells from SUR1 /  mice were dialyzed with 0.1 mM
cAMP (Fig. 7 E). These ﬁndings therefore raise the in-
teresting alternative possibility that SUR1 somehow is
involved in the exocytotic process. It is important to
note that both cAMP-GEFII and Rim2 are transcribed
in the SUR1 /  B-cells (Fig. 8). Although PCR data
cannot be equated to protein levels, these results never-
theless argue that the loss of PKA-independent cAMP-
induced exocytosis cannot simply be attributed to the
absence of the effector proteins. It may seem surprising
that whereas our data indicate that GLP-1 retains a
good stimulatory action in isolated islets, in vivo experi-
ments on the same SUR1 /  mouse strain suggest the
complete loss of GLP-1–stimulated secretion (Shiota et
al., 2002 and unpublished data). Although we are un-
able to provide a simple explanation to this discrep-
ancy, this observation might indicate that the PKA-inde-
pendent component of cAMP-induced exocytosis plays
a particularly important role for incretin-stimulated in-
sulin secretion in vivo. It should be noted that the PKA-
independent action of cAMP is operational at higher
intracellular cAMP concentrations than the PKA-
dependent mechanism (Fig. 3 D) and one possible ex-
planation is therefore that stimulation with GLP-1 re-
sulted in a larger increase in intracellular cAMP levels
in the in vitro experiments than that attained in vivo.
This concept would in fact be in accordance with the
Figure 9. Sulfonylureas retain ability
to stimulate exocytosis in SUR1 / 
B-cells. (A-B) Changes in cell capaci-
tance ( Cm) under control conditions
(ctrl) and in the presence of 0.1 mM
tolbutamide (tolb) in SUR1 /  B-cells
dialyzed with intracellular solution II
with free Ca2 -concentrations of 0.17
 M (A) or 1.5  M (B), respectively.
Cyclic AMP was included at a concen-
tration of 0.1 mM to promote granule
mobilization (Renström et al., 1997).
Traces shown are representative of 6–11
experiments. (C and D) Tolbutamide-
induced granular acidiﬁcation in wild-
type (C) and SUR1 /  B-cells (D). Acid-
iﬁcation is estimated as the relative in-
crease (in %) in the initial LSG-signal
( F/Fo) after addition of tolbutamide.
(E) Relative change in LSG ﬂuores-
cence in wild-type (wt) and SUR1 / 
B-cells 60 s after addition of tolbuta-
mide. Data are mean values  SEM of
7–8 experiments.T
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observations of Nakazaki et al. (2002), who found that
whereas GLP-1 failed to stimulate insulin secretion, for-
skolin retained the ability to potentiate insulin secre-
tion and especillay so when applied in the presence of
IBMX.
PKA-independent Effect of cAMP Involves Stimulation of Cl  
Inﬂux and Granular Acidiﬁcation
We and others have demonstrated previously that sulfo-
nylureas stimulate exocytosis in B-cells via an effect ex-
erted on the secretory machinery itself and that is not
mediated by closure of plasma membrane KATP-channels
(Flatt et al., 1994; Eliasson et al., 1996; Tian et al., 1998;
Barg et al., 1999). This effect remained observable in the
presence of forskolin but disappeared when PKC was
maximally activated by the phorbol ester PMA or inhib-
ited by bisindolylmaleimide (Eliasson et al., 1996). The
ability of sulfonylureas to stimulate exocytosis in SUR1 / 
B-cells therefore suggests that inactivation of this gene
with resultant suppression of the PKA-independent ac-
tion does not interfere with the ability of PKC activation
to stimulate secretion. Indeed, it has been reported re-
cently that the potency of PMA to stimulate insulin secre-
tion is at least as strong in the SUR1 /  islets as in their
wild-type counterparts (Nakazaki et al., 2002).
The ability of sulfonylureas to stimulate exocytosis in
B-cells may not only be of pharmacological signiﬁcance.
It can be speculated that it contributes to the metabolic
regulation of insulin secretion (i.e., the “augmenting” or
“KATP channel–independent” effects of glucose on insu-
lin release; Henquin, 2000; Henquin et al., 2002). The
importance of the metabolic state for exocytosis is wit-
nessed by the prompt (within a few seconds) inhibition
when the cytoplasmic ATP/ADP-ratio is lowered by ﬂash
photolysis of caged ADP even if ATP and Ca2  are
present at levels that would otherwise be stimulatory
(Barg et al., 2002a). This effect of ADP can be reversed
by tolbutamide and in the simultaneous presence of the
sulfonylurea and ADP, exocytosis proceeds at the same
rate as in the presence of ATP alone (Barg et al., 2001a).
A recent model postulates that the inhibitory and
stimulatory effects of ADP and tolbutamide on exocyto-
sis are secondary to changes in granular Cl  ﬂuxes and
pH; stimulation of exocytosis occurs upon intragranu-
lar acidiﬁcation and activation of Cl  inﬂux (Barg et
al., 2001a; Renström et al., 2002a). We now extend
these observations and demonstrate that binding of
cAMP to cAMP-GEFII stimulates exocytosis via the
same mechanism. We also provide evidence that the
poor incretin effect characterizing B-cells from SUR1 / 
mice associates with the failure of cAMP to activate
these processes (Fig. 10).
Model
In Fig. 11 we outline a hypothetical model that appears
to account for our observations. We propose that
Figure 10. Granular Cl  ﬂuxes and pH in wild-type and SUR1 / 
B-cells. Changes in insulin granule pH estimated as changes in Ly-
soSensor-Green™ DND-189 (LSG) ﬂuorescence and detected by
confocal imaging. (A) Mean changes in LSG ﬂuorescence (in per-
centage of initial values; F/F0)   SEM recorded when using a Ca2 -
containing pipette solution (n   6; ctrl), with cAMP (0.1 mM; n   5;
cAMP) added to the pipette solution, and when both cAMP and Rp-
cAMPS (0.5 mM; n   4; Rp cAMPS) were included. The arrow in-
dicates the time at which the standard whole-cell conﬁguration were
established with the onset of wash-in of the pipette solution. The top
trace (PB) represents (F/F0) parallel recordings in intact (whole-
cell conﬁguration not established) neighboring cells (n   15), pro-
viding an estimate of the extent of photo-bleaching in these experi-
ments. (B) Same as in A but recorded on B-cells isolated from
SUR /  mice under control conditions (n   4, ctrl) and in the pres-
ence of 0.1 mM cAMP (n   4, cAMP). (C) Mean decreases in LSG
ﬂuorescence (in percentage of initial; [F0   F]/F0)   SEM, mea-
sured 60 s after standard whole-cell establishment, under the respec-
tive condition as indicated. All experiments (except the left panel la-
beled PB) were conducted in the presence of 1.5  M free intracellu-
lar Ca2 . *P   0.05.T
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SUR1, in addition to its well-known role in the forma-
tion of functional KATP-channels (see i.e., Ashcroft and
Gribble, 1998), also facilitates the interaction between
cAMP-GEFII and downstream effector proteins includ-
ing RIM2. The ability of SUR1 itself to associate with
cAMP-GEFII is suggested by the original identiﬁcation
of cAMP-GEFII in insulin-secreting cells by yeast-two-
hybrid screening of a mouse cDNA library using SUR1
as the bait (Ozaki et al., 2000). RIM proteins have been
proposed to subserve scaffolding roles in neurons
(compare Wang et al., 1997; Schoch et al., 2002) and it
is easy to imagine how SUR1, Rim2, and cAMP-GEFII
can give rise to a molecular net of protein–protein in-
teractions in the B cell that culminates in the priming
of the insulin secretory granules. The ability of sulfo-
nylureas to stimulate exocytosis in B-cells from SUR1 / 
mice reinforces previous data, indicating that the gran-
ular sulfonylurea-binding protein (gSUR) is distinct
from SUR1 (Barg et al., 1999; Renström et al., 2002a).
We have suggested that gSUR, via interaction with the
ClC3 channels and regulation of granular Cl  ﬂuxes,
modulates the release competence of the insulin gran-
ules (Barg et al., 2001a). We now extend this concept
and propose that cAMP-GEFII, by assembling with the
gSUR–ClC3 complex, promotes granule priming. A
tight association of cAMP-GEFII, gSUR, and ClC3 is in-
deed suggested by the ﬁnding that the stimulatory ac-
tion of sulfonylureas is lost following down-regulation
of cAMP-GEFII using antisense ODNs or a dominant
negative construct (Fig. 4). It is unlikely that the sulfo-
nylureas bind directly to cAMP-GEFII because the latter
protein has a molecular weight of 110 kD and no sulfo-
nylurea-binding proteins of this molecular weight have
been identiﬁed. We propose that the binding of sulfo-
nylureas to gSUR stabilizes the interaction between
cAMP-GEFII/gSUR and ClC3 thus facilitating granule
priming. We acknowledge that this scenario by neces-
sity is speculative because the identity of gSUR remains
enigmatic and the interaction with other proteins and
effects of sulfonylureas have accordingly not been pos-
sible to test.
To account for the loss of PKA-independent stimula-
tion of exocytosis in SUR1 /  B-cells, we propose that
the cAMP-GEFII–gSUR1 complex fails to associate cor-
rectly with the granular ClC3-channel in the absence of
SUR1. Accordingly, the ability of cAMP to exert its PKA-
independent effect on granular Cl  ﬂuxes (Fig. 10)
and exocytosis (Fig. 7) is lost. This concept would ac-
count for the observations that the effects of both
cAMP and sulfonylureas converge at the level of granu-
lar acidiﬁcation. We ﬁnally emphasize that although
SUR1, cAMP-GEFII, ClC3, and gSUR are important for
granule priming, membrane fusion still depends on
the SNARE proteins VAMP2, syntaxin-1, SNAP25, and
the Ca2 -sensor synaptotagmin (Jacobsson et al., 1994;
Lin and Scheller, 2000; Satin, 2000) and exocytosis can
therefore proceed in the absence of cAMP or in SUR1-
deﬁcient B-cells, albeit at a lower rate than in wild-type
B-cells.
The interactions between cAMP and sulfonylureas
and their respective receptors are clearly very complex.
However, based on the present ﬁndings as well as those
published by others (Nakazaki et al., 2002; Shiota et al.,
2002) it now seems justiﬁable to conclude that the role
of SUR1 in the B cell extends beyond being a subunit
of the KATP-channel and that it also plays an unex-
pected but important role in the control of the insulin
secretory machinery.
Lena Eliasson, Xiaosong Ma, and Erik Renström contributed
Figure 11. Schematic summarizing
the interactions between cAMP-GEFII,
SUR, and exocytosis-regulating pro-
teins. See text for details. SG, secretory
granule; ClC3, ClC3 chloride channel,
SUR1, sulfonylurea receptor.T
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